0.42
+0.081(+23.89%)
Currency In USD
| Previous Close | 0.34 |
| Open | 0.55 |
| Day High | 0.56 |
| Day Low | 0.39 |
| 52-Week High | 29 |
| 52-Week Low | 0.3 |
| Volume | 124.32M |
| Average Volume | 17.76M |
| Market Cap | 4.74M |
| PE | -0.03 |
| EPS | -13.83 |
| Moving Average 50 Days | 0.63 |
| Moving Average 200 Days | 5.03 |
| Change | 0.08 |
If you invested $1000 in ReShape Lifesciences Inc. (RSLS) since IPO date, it would be worth $0 as of May 03, 2025 at a share price of $0.42. Whereas If you bought $1000 worth of ReShape Lifesciences Inc. (RSLS) shares 5 years ago, it would be worth $0.06 as of May 03, 2025 at a share price of $0.42.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium
GlobeNewswire Inc.
Yesterday at 12:31 PM GMT
Vagal Neuromodulation Offers a Novel Approach to Treating Diabetes and Hypoglycemia Device Demonstrates the Ability to Modulate Glucose Levels Without Cardiac Side Effects, Overcoming a Key Limitation Of Conventional Vagal Stimulation Techniques IRVI
ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System
GlobeNewswire Inc.
Apr 28, 2025 12:31 PM GMT
Patent Expands and Strengthens Intellectual Property Portfolio Around a Swallowable and Degradable Intragastric DeviceIRVINE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
GlobeNewswire Inc.
Apr 21, 2025 12:31 PM GMT
Vagal Neuromodulation Offers a Novel Approach to Treating Type 2 Diabetes and Hypoglycemia Patent Enables Equivalent Efficacy with 10 times Lower Energy Consumption Than Current Device Fully Compatible with Standard Implantable Pulse Generators, Enab